Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 605 across all filing types
Latest filing 2022-04-06 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns- Changes in issued share capital and/or share buyback
Share Issue/Capital Change Classification · 100% confidence The document is a Next Day Disclosure Return filed by Kindstar Globalgene Technology, Inc. It details changes in issued share capital, including share repurchases and exercises of options, with specific dates and quantities. The document references compliance with the Main Board Listing Rules and GEM Listing Rules of the Stock Exchange of Hong Kong. It includes confirmations by an executive director and CFO regarding the authorization and compliance of these share capital changes. The content focuses on share capital changes and repurchases, not on financial results, management changes, or other report types. This matches the definition of a Share Issue/Capital Change filing, which covers announcements regarding new share issues, stock splits, or other capital changes. The document length is over 10,000 characters and contains detailed data, so it is not merely an announcement of a report. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2022-04-06 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed disclosures about share option exercises, repurchases of shares, and confirmations related to compliance with listing rules on the Stock Exchange of Hong Kong. The content focuses on equity issuer disclosures about share capital changes and repurchases, consistent with regulatory requirements for immediate disclosure of such events. There is no indication that this is a full financial report, earnings release, or management discussion. The document is a regulatory disclosure about share capital changes and repurchases, which aligns with the category for Transaction in Own Shares (POS). The document length is over 12,000 characters and contains substantive data, not just an announcement or certification, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA). Therefore, the best classification is POS (Transaction in Own Shares).
2022-04-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return report on movements in securities, specifically focusing on share capital, issued shares, share options, and confirmations related to securities issued by Kindstar Globalgene Technology, Inc. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The content includes detailed tables of share capital changes, share options exercised, and confirmations by company officers. There is no indication that this is an annual or quarterly financial report, earnings release, or management discussion. It is a regulatory filing reporting share capital movements and confirmations related to securities issuance, which fits the category of Regulatory Filings (RNS) as it does not fit other more specific categories and is a compliance-related submission to the exchange.
2022-04-04 English
SHARE PURCHASE PURSUANT TO THE POST-IPO RSU SCHEME
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the purchase of shares pursuant to a Post-IPO RSU (Restricted Stock Unit) Scheme. It details the number of shares purchased, the price range, and the purpose of the purchase as awards for selected participants. There is no financial report, earnings data, or management discussion. The document is focused on a share purchase related to the company's own shares under an employee incentive scheme. This fits the category of a Transaction in Own Shares (POS), which covers share repurchase or issuance activities by the company itself. The document length is short and it is not an announcement of a report publication or a regulatory filing. Therefore, the best classification is POS with high confidence.
2022-03-31 English
SHARE PURCHASE PURSUANT TO THE POST-IPO RSU SCHEME
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the company's share purchase pursuant to a Post-IPO Restricted Share Unit (RSU) Scheme. It discusses the company's plan to have the RSU Trustee acquire shares on-market to satisfy awards under the scheme. The document does not contain financial statements, earnings data, or detailed financial analysis. It is a regulatory announcement about share transactions related to employee incentive plans. The document length is 4252 characters, which is relatively short and focused on a specific corporate action. This fits best under the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares, including share purchases for RSU schemes. Therefore, the appropriate classification is POS with high confidence.
2022-03-25 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2021
Annual Report Classification · 95% confidence The document is titled 'ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2021' and contains detailed consolidated financial results, including revenue, gross profit, segment results, and adjusted net income for the full fiscal year ending December 31, 2021. It includes comprehensive financial data, business segment reviews, and outlook, which are typical components of an Annual Report. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement or summary. There is no indication that this is merely an announcement of a report or a certification. Therefore, the document fits the definition of an Annual Report (10-K equivalent). FY 2021
2022-03-25 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.